Zynerba Pharmaceuticals
ZYNE
#9571
Rank
S$90.23 M
Marketcap
S$1.67
Share price
0.00%
Change (1 day)
184.60%
Change (1 year)

Revenue for Zynerba Pharmaceuticals (ZYNE)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zynerba Pharmaceuticals from 2014 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A-100%
2018 S$0.11 M
2017 N/A-100%
2016 S$0.01 M-97.34%
2015 S$0.39 M-63.14%
2014 S$1.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA